0000950170-23-071939.txt : 20231220
0000950170-23-071939.hdr.sgml : 20231220
20231220171355
ACCESSION NUMBER: 0000950170-23-071939
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231218
FILED AS OF DATE: 20231220
DATE AS OF CHANGE: 20231220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KARBE FRANK
CENTRAL INDEX KEY: 0001276700
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39864
FILM NUMBER: 231502125
MAIL ADDRESS:
STREET 1: C/O MYOVANT SCIENCES INC.
STREET 2: 2000 SIERRA POINT PARKWAY, 9TH FLOOR
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Better Therapeutics, Inc.
CENTRAL INDEX KEY: 0001832415
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 548 MARKET ST. #49404
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94101
BUSINESS PHONE: 415-887-2311
MAIL ADDRESS:
STREET 1: 548 MARKET ST. #49404
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94101
FORMER COMPANY:
FORMER CONFORMED NAME: Mountain Crest Acquisition Corp II
DATE OF NAME CHANGE: 20201116
4
1
ownership.xml
4
X0508
4
2023-12-18
0001832415
Better Therapeutics, Inc.
BTTX
0001276700
KARBE FRANK
C/O BETTER THERAPEUTICS, INC.
548 MARKET STREET, #49404
SAN FRANCISCO
CA
94104
true
true
false
false
Chief Executive Officer
false
Common Stock
2023-12-18
4
A
false
62500
0.0
A
526516
D
The Reporting person was awarded 62,500 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024.
Includes 34,587 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on November 30, 2023.
/s/ Leslie Miller, Attorney-in-fact
2023-12-20